PCMA Outlines How PBMs Reduce Prescription Drug Costs Before the Senate HELP Committee
October 17, 2017
PCMA President and CEO Mark Merritt Testifies Before Senate HELP Committee Testifying today before the U.S. Senate Committee on Health,...
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Press Releases
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHBP Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
- Value & Outcomes-Based Contracting
PCMA Response to WSJ Op-Ed: “Insurers are Still Denying Treatments for Pre-Existing Conditions”
August 24, 2017
“Insurers are Still Denying Treatments for Pre-Existing Conditions” perfectly reflects the drug lobby’s criticism of the clinical safeguards used to...
PCMA Applauds the Administration’s Effort to Combat the Opioid Crisis
August 08, 2017
(Washington, D.C.) — As the Administration puts forward new steps to curb the rising opioid epidemic, the Pharmaceutical Care Management...
PCMA Response to Wall Street Journal PBM Article
August 07, 2017
In its attempt to find the reason for the high cost of Epipens, “Behind the Push to Keep Higher Priced...
PCMA: Inaccurate Kaiser Health News Video Sides with Drug Makers
August 04, 2017
The video (“Little Known Middlemen Who Save $$ On Medicines — But Maybe Not For You”) includes basic inaccuracies and...
July 26, 2017
DIR Reduces Part D Costs and Premiums (Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released a new...
PCMA Offers to Work with FDA chief Scott Gottlieb to Address the Opioid Crisis
July 25, 2017
The Pharmaceutical Care Management Association (PCMA) has outlined solutions that would help assure people receive opioid prescriptions only when medically...
PCMA Issues Guiding Principles, Policy Solutions to HHS on Reducing Prescription Drug Costs
July 18, 2017
(Washington, D.C.) -- The Pharmaceutical Care Management Association (PCMA) recently submitted a letter to HHS Secretary Tom Price offering policy...
July 12, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) has filed a lawsuit in federal court challenging two North Dakota...
PBMs Provide the HELP Committee with Policy Solutions to Increase Competition, Reduce Rx Costs
June 13, 2017
(Washington, D.C.)— As the Senate Committee on Health, Education, Labor and Pensions (HELP) examines the drug delivery system, the Pharmaceutical Care...
PCMA: Supreme Court Ruling on Biosimilars to Increase Competition, Reduce Drug Costs
June 12, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement regarding today’s ruling by the United States...
PCMA Report: Drugmakers Raise Prices Regardless of Rebates
June 12, 2017
(Washington, D.C.) — As the Senate Committee on Health, Education, Labor and Pensions examines the drug delivery system during...